funded by the Key Project of the National Natural Science Foundation of China(81830093);the Non-Profit Central Research Institute Fund of CAMS(2022-RC310-05,2021-RC310-003,2020-RC310-002);CAMS Initiative for Innovative Medicine(2022-I2M-2-001);the National Natural Science Foundation of China(82372944).
Yu et al.[1]reported that the tumor necrosis factor(TNF)receptor OX40(CD134)-TNF receptor-associated factor 6(TRAF6)axis mediates Lys63-linked ubiquitination and subsequent lysosomal degradation of cytotoxic T-lymphoc...
t OX40 is a costimulatory receptor that is expressed primarily on activated CD4+,CD8+,and regulatory T cells.The ligation of OX40 to its sole ligand OX40L potentiates T cell expansion,differentiation,and activation an...
supported by the National Natural Science Foundation of China(82071803,82241217,and 82271811);Fundamental Research Funds for the Central Universities(2021GCRC037);Project Funded by China Postdoctoral Science Foundation(2021M691155).
Immune checkpoint blockade(ICB),including anti-cytotoxic T-lymphocyte associated protein 4(CTLA-4),benefits only a limited number of patients with cancer.Understanding the in-depth regulatory mechanism of CTLA-4 prote...